Concepedia

Laura Morris

LM

Statistics

Publications

11

Citations

1.6K

H-Index

11

Active since

1989

Affiliations

University of Nottingham(Current)

University of Bristol

University of Missouri

Nottingham University Hospitals NHS Trust

University of British Columbia

Laura Morris is an author at University of Nottingham specializing in medicine, cancer research, and tumor biology.

ORCID

Top concepts

Publications per year

1989–2024

11

Publications

11

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 516 citations · Full text

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2022 · 382 citations · Full text

, , +3

Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 289 citations · Full text

Rab1A Is an mTORC1 Activator and a Colorectal Oncogene

Janice D. Thomas, Yanjie Zhang, Yue-Hua Wei et al. · Cancer Cell · 2014 · 266 citations · Full text

, , +6

Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial

Saul N. Faust, Richard Haynes, Christine E. Jones et al. · The Lancet Child & Adolescent Health · 2024 · 31 citations · Full text

1–5 of 11